BioSpace News Archive

Biotech Beach

Thermo Fisher Scientific’s Oncomine Dx Target Test for Non-Small Cell Lung Cancer Receives Coverage from First Regional Health Plan

Thermo Fisher Scientific today announced its Oncomine Dx Target Test has received a positive coverage decision by Regence BlueCross/BlueShield.

October 16, 2017

·

2 min read

Business

Hoth Therapeutics Announces The Addition Of Dr. Richard D Granstein, M.D. To The Company’s Technology Advisory Board

Hoth Therapeutics announced today the addition of Dr. Richard D. Granstein, M.D., to the Company’s Technology Advisory Board.

October 16, 2017

·

4 min read

Concordia Continues Discussions With Stakeholders; Defers Unsecured Interest Payment Due October 16th As It Works Toward Realignment Of Its Capital Structure

Concordia today announced that in conjunction with its ongoing efforts to realign its capital structure, it has decided to use a 30-day grace period to defer the payment of approximately $26M of interest due today on its $735M unsecured notes.

October 16, 2017

·

7 min read

Policy

ImmunoGen Announces Investigational New Drug Application for IMGN632 for Hematological Malignancies is Active

ImmunoGen, Inc. today announced that the U.S. Food and Drug Administration (FDA) has completed the safety review of its investigational new drug (IND) application for IMGN632 in patients with CD123-positive hematological malignancies.

October 16, 2017

·

4 min read

Genetown

Ironwood Pharmaceuticals Presenting Linaclotide Data at the World Congress of Gastroenterology at ACG 2017

Ironwood Pharmaceuticals, Inc. announced that the company and its collaborators are presenting clinical data for linaclotide at the World Congress of Gastroenterology (WCOG) at the American College of Gastroenterology (ACG), on October 13-18, 2017 in Orlando, Florida.

October 16, 2017

·

7 min read

Pharm Country

Celgene Corporation Release: Results from Phase 2 Studies of Oral Ozanimod in Crohn’s Disease and Ulcerative Colitis to Be Presented at World Congress of Gastroenterology at ACG2017

Celgene Corporation today announced that phase 2 data of investigational compound ozanimod in Crohn’s disease and ulcerative colitis will be presented at the World Congress of Gastroenterology at ACG2017 (WCOG at ACG2017) in Orlando.

October 16, 2017

·

10 min read

FDA

Instrumentation Laboratory Receives U.S. FDA Clearance for HemosIL AcuStar HIT-IgG(PF4-H)Assay and Controls

Instrumentation Laboratory today announced the 510(k) clearance of the HemosIL AcuStar HIT-IgG(PF4-H) Assay and HemosIL AcuStar HIT Controls by the FDA.

October 16, 2017

·

4 min read

Ramaswamy’s Myovant Sciences Scores $140M

Myovant Sciences has secured up to $140 million in flexible financing commitments from NovaQuest Capital Management and Hercules Capital.

October 16, 2017

·

5 min read

Hemovent Successfully Debuts ExtraCorporeal Life Support (ECLS) Device from its Artificial Lung Platform

Hemovent GmbH announced today that its ECLS device got overwhelmingly enthusiastic clinician feedback at REANIMATE 4, one of the leading-edge endovascular resuscitation conferences, organized by the ED ECMO Project.

October 16, 2017

·

2 min read

Business

Materia And Evonik Reach Agreement On Catalyst License

Materia has entered into a license agreement with Evonik Industries, related to olefin metathesis catalysts, following a patent infringement case between the two companies.

October 16, 2017

·

1 min read